Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Extracorporeal membrane oxygenation (ECMO) is a form of life support used for babies, children and adults with life-threatening heart and/or lung problems. ECMO provides time for the body to rest and recover by doing the work of the heart and lungs. This gives the patient time to rest and heal from the underlying illness. It is a modified form of heart-lung bypass and is used for a longer period than the machines used in the operating room during open-heart surgery. ECMO may be used to provide heart or lung support for children with a variety of conditions. Children who need ECMO may have pneumonia, congenital diaphragmatic hernia, pulmonary hypertension, sepsis, congenital heart conditions, end-state cardiac or respiratory failure etc.
The global extracorporeal membrane oxygenation machine market is observing significant growth owing to surging incidences of chronic obstructive pulmonary disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures. The market is further boosted by global increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders. Active role of healthcare agencies and government in creating awareness about various diseases is also expected to facilitate the growth of extracorporeal membrane oxygenation machine, thereby supporting market development. However, the market is hindered by lack of skilled professionals and the high cost of extracorporeal membrane oxygenation procedures.
The report analyses the global extracorporeal membrane oxygenation machine market based on component type, modality, application and geography.
Based on component type, the market is categorized into pumps such as, roller pumps and centrifugal pumps; oxygenators; heat exchangers; saturation monitors and others including bladders, cannulas etc. Indwelling cannulae, either venous or arterial, can be placed under direct vision or through a percutaneous approach, ideally guided by ultrasound or fluoroscopy. The size and length of the cannula vary depending on the patient surface area, insertion site, type of circuit, and intended use. Centrifugal pumps are used as they are reliable and easy to maintain.
Various modalities of the extracorporeal membrane oxygenation machine market are Venoarterial (VA), Venovenous (VV) and Arteriovenous (AV). The veno-arterial ECMO (VA-ECMO) allows gas exchange and haemodynamic support while blood is pumped from the venous to the arterial side. Whereas, the arterio-venous ECMO (AV-ECMO) facilitates gas exchange by using the patient's own arterial pressure to pump the blood from the arterial to the venous side.
Furthermore, different applications included this market are categorized into respiratory, cardiac and extracorporeal cardiopulmonary resuscitation (ECPR). VA-ECMO is indicated in patients with refractory cardiogenic shock who have an underlying potentially reversible heart condition, although it can also be used as a bridge to a ventricular assist device or cardiac transplantation.
By geography, the global extracorporeal membrane oxygenation machine market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada. As per the American Heart Association, coronary heart disease is the leading cause of deaths (45.1%), followed by cardiovascular disease in the United States, stroke (16.5%), and heart failure (8.5%). About 5.7 million adults in the United States die of a heart failure every year and ECMO has the potential to reduce the percentage of in-hospital failures. Furthermore, Asia Pacific is expected to witness lucrative growth over the forecast period owing to supportive government initiatives and improving healthcare infrastructure. Additionally, economic developments in countries, such as India and China, are expected to help spur the market growth. Huge population base with low per capita income in the region led to high demand for affordable treatment options.
The leading extracorporeal membrane oxygenation machine market players are Alung Technologies, Inc., Eurosets S.R.L., Getinge Group, Livanova PLC, Medtronic PLC, Microport Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Terumo Corporation and Xenios AG (Fresenius Medical Care AG & Co. KGaA). In 2018, Medtronic Plc. collaborated with the Sayler Biomedical LLC, for the development of Century heart Lung machine. The collaboration has made the Medtronic’s product available for customers internationally.
The global extracorporeal membrane oxygenation machine market is segmented based on component type, modality, application and geography. Based on component type, the market is categorized into pumps such as, roller pumps and centrifugal pumps; oxygenators; heat exchangers; saturation monitors and others including bladders, cannulas etc.
Various modalities of the extracorporeal membrane oxygenation machine market are Venoarterial (VA), Venovenous (VV) and Arteriovenous (AV). The veno-arterial ECMO (VA-ECMO) allows gas exchange and haemodynamic support while blood is pumped from the venous to the arterial side.
Furthermore, different applications included this market are categorized into respiratory, cardiac and extracorporeal cardiopulmonary resuscitation (ECPR). VA-ECMO is indicated in patients with refractory cardiogenic shock who have an underlying potentially reversible heart condition, although it can also be used as a bridge to a ventricular assist device or cardiac transplantation.
By geography, the global extracorporeal membrane oxygenation machine market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world. In 2018, North America held the largest revenue share mainly due to factors such as government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in U.S. and Canada.
Why to buy this report:
